Entries by Citron Research


Updated Citron Report Card — The Scoreboard Doesn’t Lie

*The market's run since January 2013 has been plenty challenging for shortsellers.   Keep in mind that headlines defined market conditions like this. : Rising Markets Batter Short Sellers Investors Betting Stocks Will Fall See Worst Losses in Decade http://online.wsj.com/news/articles/SB10001424127887323423804579024883191034634 So we thought it was a good time to offer a review of our work.  We […]

, , ,

Questcor is Deceiving the FDA and Investors

Citron Reports Further Results from Laboratory Testing: Questcor is Deceiving the FDA and Investors H.P. Acthar Gel’s Specified Active Ingredient Less Than 20% of the Label Specification Bioactivity of Deamidated Hormone Fragment Far Lower than Pure ACTH The FDA has been Notified Citron reports on further lab data submitted to FDA, that the contents Questcor’s only […]


What is Really in HP Acthar Gel?

UPDATE. (9:15 AM PST) We know readers might reasonably wonder:  Were Acthar Gel test samples mishandled and/or degraded in some way before or during testing?  In fact, the tested vials came from two sources, two different batches, and the second set came straight from an official Acthar distributor, with full chain-of-custody documentation. Both sample sets tested identically: […]